IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: The degree of peripheral lymphopenia was higher in CML patients receiving TKIs plus IFN-α [1140/μL of blood (95% CI 811–1603)] compared with individuals receiving TKIs only [1853/μL (95% CI 1567–2191); p = 0.039].